Companies: 10,795·Total market cap: $144.5T
hVIVO plc

hVIVO plc

OPORFOTCHealthcare● Active
$0.35
+$0.26(+306.50%)
Market Cap$240940378
P/E Ratio
52W High$0.35
52W Low$0.0861

hVIVO plc (OPORF) Revenue

Annual & quarterly revenue history · segment & region breakdown

OPORF · revenue · updated Jun 9, 2026

Core revenue metrics

hVIVO plc trailing twelve-month (TTM) revenue is $0.11B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.11B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
2.18×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$368K
301 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · hVIVO plc SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
OPORF revenue by year · OPORF revenue history · OPORF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income hVIVO plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

hVIVO plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from hVIVO plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

OPORF revenue · 4 questions

OPORF's trailing twelve-month (TTM) revenue is $0.11B. That is an increase of 0.00% year-over-year from — in FY.

OPORF revenueOPORF annual revenuewhat is OPORF revenueOPORF TTM revenue

Source: FMP · hVIVO plc SEC filings · GAAP · hVIVO plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026